article thumbnail

FDA approves first T cell therapy in solid tumours

Drug Discovery World

“The approval of Amtagvi represents the culmination of scientific and clinical research efforts leading to a novel T cell immunotherapy for patients with limited treatment options.” Amtagvi is the first FDA-approved tumour-derived T cell immunotherapy.

article thumbnail

FDA approval represents ‘transformational progress’ in hypertension

Drug Discovery World

I am convinced that with the data we have seen, the approval of Tryvio heralds a new era of endothelin research beyond hypertension, where we intend to investigate the utility of aprocitentan for first-in-class applications in new indications.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves new treatment option for anaemia due to kidney disease

Drug Discovery World

Diana Spencer, Senior Digital Content Editor, DDW The post FDA approves new treatment option for anaemia due to kidney disease appeared first on Drug Discovery World (DDW).

article thumbnail

FDA approves Izervay for geographic atrophy

Drug Discovery World

The new complement C5 inhibitor is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across two Phase III clinical trials. The FDA approval of Izervay is great news for the retina community and our patients suffering from GA.”

article thumbnail

FDA approves Covid-19 mAb for emergency use in immunocompromised

Drug Discovery World

Diana Spencer, Senior Digital Content Editor, DDW The post FDA approves Covid-19 mAb for emergency use in immunocompromised appeared first on Drug Discovery World (DDW).

article thumbnail

FDA approves first gene therapy for Duchenne muscular dystrophy

Drug Discovery World

“If EMBARK confirms the benefits seen in our prior trials, Sarepta will move rapidly to submit a BLA supplement to expand the approved label as broadly as good science permits.” The post FDA approves first gene therapy for Duchenne muscular dystrophy appeared first on Drug Discovery World (DDW).

article thumbnail

FDA approves second indication for Lilly’s BTK inhibitor Jaypirca

Drug Discovery World

Jaypirca is the first FDA-approved non-covalent (reversible) BTK inhibitor. ” The post FDA approves second indication for Lilly’s BTK inhibitor Jaypirca appeared first on Drug Discovery World (DDW).